Should asymptomatic progression following definitive local treatment for prostate cancer be treated?

P. Lillis, I. M. Thompson

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Asymptomatic progression following definitive therapy for prostate cancer can take the form of a detectable prostate-specific antigen (PSA) or local recurrence following radical prostatectomy or a rising PSA or palpable recurrence following radiotherapy. Options for treatment include hormonal therapy, radiotherapy, salvage surgery, and experimental therapies. Although such forms of treatment have known effects on intermediate endpoints, such as reduction of PSA, the overall effect on survival and quality of life is uncertain.

Original languageEnglish (US)
Pages (from-to)703-712
Number of pages10
JournalHematology/Oncology Clinics of North America
Volume10
Issue number3
DOIs
StatePublished - Jan 1 1996

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Should asymptomatic progression following definitive local treatment for prostate cancer be treated?'. Together they form a unique fingerprint.

  • Cite this